InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Zeocin® | AdrA as a Potential Immunomodulatory Candidate for STING-Mediated Antiviral T... | 2020 | J Immunol. | Rodriguez-Garcia E. et al. | DOI: 10.4049/jimmunol.2000953 |
| QUANTI-Luc™: Luciferase Detection Reagent | AdrA as a Potential Immunomodulatory Candidate for STING-Mediated Antiviral T... | 2020 | J Immunol. | Rodriguez-Garcia E. et al. | DOI: 10.4049/jimmunol.2000953 |
| RAW-Lucia™ ISG-KO-STING Cells | AdrA as a Potential Immunomodulatory Candidate for STING-Mediated Antiviral T... | 2020 | J Immunol. | Rodriguez-Garcia E. et al. | DOI: 10.4049/jimmunol.2000953 |
| 2'3'-cGAMP | SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and... | 2020 | Nat Commun. | Olagnier D. et al. | DOI: 10.1038/s41467-020-18764-3. |
| HSV-60 | SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and... | 2020 | Nat Commun. | Olagnier D. et al. | DOI: 10.1038/s41467-020-18764-3. |
| QUANTI-Luc™: Luciferase Detection Reagent | A systematic identification of anti-inflammatory active components derived fr... | 2020 | Sci Rep. | Chen TF. et al. | DOI: 10.1038/s41598-020-74201-x |
| QUANTI-Blue™ | A systematic identification of anti-inflammatory active components derived fr... | 2020 | Sci Rep. | Chen TF. et al. | DOI: 10.1038/s41598-020-74201-x |
| THP1-Dual™ Cells | A systematic identification of anti-inflammatory active components derived fr... | 2020 | Sci Rep. | Chen TF. et al. | DOI: 10.1038/s41598-020-74201-x |
| HKCA | T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis. | 2020 | Nat Commun. | Napier R.J. et al. | DOI: 10.1038/s41467-020-18961-0 |
| OVA peptides | A general strategy towards personalized nanovaccines based on fluoropolymers ... | 2020 | Nat Nanotechnol. | Xu J. et al. | DOI: 10.1038/s41565-020-00781-4 |
| Mouse TLR4 HEK293 Reporter Cells (NF-κB and IL-8) | A general strategy towards personalized nanovaccines based on fluoropolymers ... | 2020 | Nat Nanotechnol. | Xu J. et al. | DOI: 10.1038/s41565-020-00781-4 |
| Hygromycin B Gold | A general strategy towards personalized nanovaccines based on fluoropolymers ... | 2020 | Nat Nanotechnol. | Xu J. et al. | DOI: 10.1038/s41565-020-00781-4 |
| OVA protein | A general strategy towards personalized nanovaccines based on fluoropolymers ... | 2020 | Nat Nanotechnol. | Xu J. et al. | DOI: 10.1038/s41565-020-00781-4 |
| Double NF-κB–Readout HEK293 Reporter Cells | A general strategy towards personalized nanovaccines based on fluoropolymers ... | 2020 | Nat Nanotechnol. | Xu J. et al. | DOI: 10.1038/s41565-020-00781-4 |
| ATP | Riboflavin, vitamin B2, attenuates NLRP3, NLRC4, AIM2, and non-canonical infl... | 2020 | Sci Rep. | Ahn H. & Lee GS. | DOI: 10.1038/s41598-020-76251-7 |
| IL-6 Reporter HEK 293 Cells | Lack of evidence for expression and function of IL-39 in human immune cells. | 2020 | PLoS One. | Ecoeur F. et al. | DOI: 10.1371/journal.pone.0242329 |
| HEK-Blue™ Selection | Lack of evidence for expression and function of IL-39 in human immune cells. | 2020 | PLoS One. | Ecoeur F. et al. | DOI: 10.1371/journal.pone.0242329 |
| QUANTI-Blue™ | Lack of evidence for expression and function of IL-39 in human immune cells. | 2020 | PLoS One. | Ecoeur F. et al. | DOI: 10.1371/journal.pone.0242329 |
| Normocin® - Antimicrobial Reagent | Lack of evidence for expression and function of IL-39 in human immune cells. | 2020 | PLoS One. | Ecoeur F. et al. | DOI: 10.1371/journal.pone.0242329 |
| IL-23 Reporter HEK 293 Cells | Lack of evidence for expression and function of IL-39 in human immune cells. | 2020 | PLoS One. | Ecoeur F. et al. | DOI: 10.1371/journal.pone.0242329 |